Concepedia

Ariel Galapo Kann

AG

Statistics

Publications

10

Citations

649

H-Index

10

Active since

2013

Affiliations

Hospital Alemão Oswaldo Cruz(Current)

Queen Mary University of London

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

AC Camargo Hospital

Azienda Ospedaliera S.Maria

Ariel Galapo Kann is an author at Hospital Alemão Oswaldo Cruz specializing in cancer therapeutics, medicine, and urology.

ORCID

Top concepts

Publications per year

2013–2025

10

Publications

10

Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer

Thomas Powles, James W.F. Catto, Matthew D. Galsky et al. · New England Journal of Medicine · 2024 · 245 citations · Full text

Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial

Sumanta K. Pal, Robert G. Uzzo, José A. Karam et al. · The Lancet · 2022 · 214 citations · Full text

, , +9

The Burden of Uncontrolled Cardiovascular Risk Factors in Men With Prostate Cancer

Harry Klimis, Jehonathan H. Pinthus, Nazanin Aghel et al. · JACC CardioOncology · 2023 · 50 citations · Full text

ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer

Thomas Powles, Ariel Galapo Kann, Daniel Castellano et al. · New England Journal of Medicine · 2025 · 32 citations

Renal Medullary Carcinoma Response to Chemotherapy: a Referral Center Experience in Brazil

Marina Cavalcanti Maroja Silvino, Camila Motta Venchiarutti Moniz, Gustavo Henrique Munhoz Piotto et al. · Rare Tumors · 2013 · 28 citations · Full text

, , +13

1–5 of 10